on Zomedica Corp. (NASDAQ:ZOM)
Zomedica Secures CE Mark for TRUVIEW Digital Microscope & Telepathology System
Zomedica Corp., a veterinary health company, has announced it has secured the CE Mark for its TRUVIEW™ digital microscopy and telepathology platform. This certification confirms the system's compliance with EU health, safety, and environmental standards. The approval opens commercialization opportunities for the TRUVIEW microscope across the European Economic Area.
The TRUVIEW platform boasts advanced diagnostic features such as LiquiView™ liquid lens technology and the proprietary TRUprep™ automated slide preparation system. This integrated solution enhances diagnostic accuracy and efficiency for veterinary professionals.
Bill Campbell, VP of Imaging at Zomedica, stated that the TRUVIEW microscope automates slide preparation and offers telepathology services, improving both precision and operational efficiency. The platform's telepathology feature allows real-time remote consultations, fostering collaboration among veterinary professionals.
CEO Larry Heaton emphasized that securing the CE Mark is a significant milestone for Zomedica, setting a new standard for veterinary diagnostics in Europe and globally.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Zomedica Corp. news